Research Article
Efficacy of Sofosbuvir/Daclatasvir in a Single Tablet for Treating Chronic Viral Hepatitis C
Table 1
Baseline demographic characteristics and laboratory data of the study patients.
| | Age | Mean | SD |
| | | 51.4 | 14.4 |
| | Variables | Number (n = 99) | % |
| | Sex | | | | Female | 53 | 53.5 | | Male | 46 | 46.5 | | Genotype | | | | 1a | 3 | 03.03 | | 1b | 47 | 47.47 | | 2 | 17 | 17.17 | | 2a/2c | 2 | 2.0 | | 3 | 2 | 2.0 | | 4 | 1 | 1.0 | | Missing data | 27 | 27.27 | | Liver status | | | | Cirrhotic | 19 | 19.19 | | Noncirrhotic | 80 | 80.80 | | Fibrosis score | | | | F4 | 19 | 19.19 | | History of treatment | | | | Treatment-naïve | 93 | 93.93 | | Treatment-experienced | 5 | 05.05 | | Medical history | | | | Obesity | 24 | 24.2 | | Diabetes | 17 | 17.2 | | HBV results | | | | Positive | 1 | 01.01 | | Negative | 98 | 98.98 | | Laboratory data (mean ± SD) | | | | ALT (IU/L) | 54.41 (50.3) | — | | WBC (×103)/mm3 | 7.06 (4.8) | — | | PN | 4.8 (7.5) | — | | Hb (g/dL) | 13.5 (1.9) | — | | Platelet (×103)/mm3 | 223.05 (75.6) | — |
|
|
